Systemic Moxifloxacin in Streptococcus viridans Endophthalmitis

REFERENCES

• Verbraeken H. Treatment of postoperative endophthalmitis. Ophthalmologica. 1995;209(3):165–171.
   PubMed Web of Science ®Google Scholar
• Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy Study. Am J Ophthalmol. 1996;122(1):1–17.
   PubMed Web of Science ®Google Scholar
• Benz MS, Scott IU, Flynn HW, et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004;137(1):38–42.
   PubMed Web of Science ®Google Scholar
• Pijl BJ, Theelen T, Tilanus MA, et al. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. Am J Ophthalmol. 2010;149(3):482–487.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Shibata N, Osada H, et al. Vitreous and aqueous penetration of orally and topically administered moxifloxacin. Ophthalmic Res. 2011;46(3):113–117.
   PubMed Web of Science ®Google Scholar
• Bronner S, Jehl F, Peter JD, et al. Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrob Agents Chemother. 2003;47(5):1621–1629.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim SY. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis. Invest Ophthalmol Vis Sci. 2011;52(3):1742–1747.
   PubMed Web of Science ®Google Scholar
• Coykendall AL. Classification and identification of the viridans streptococci. Clin Microbiol Rev. 1989;2(3):315–328.
   PubMed Web of Science ®Google Scholar
• Frandsen EV, Pedrazzoli V, Kilian M. Ecology of viridans streptococci in the oral cavity and pharynx. Oral Microbiol Immunol. 1991;6(3):129–133.
   PubMedGoogle Scholar
• Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002;15(4):613–630.
   PubMed Web of Science ®Google Scholar
• Alestig K, Hogevik H, Olaison L. Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium. Scand J Infect Dis. 2000;32(4):343–356.
   PubMedGoogle Scholar
• Chen E, Lin MY, Cox J, et al. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina. 2011;31(8):1525–1533.
   PubMed Web of Science ®Google Scholar
• McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31(4):654–661.
   PubMed Web of Science ®Google Scholar
• Mokaddas EM, Salako NO, Philip L, et al. Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution. J Clin Microbiol. 2007;45(7):2162–2165.
   PubMed Web of Science ®Google Scholar
• Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82–98.
   PubMedGoogle Scholar
• Jacqueline C, Batard E, Perez L, et al. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Antimicrob Agents Chemother. 2002;46(12):3706–3711.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cerrato V, McCoig CC, Michelow IC, et al. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis. Antimicrob Agents Chemother. 2001;45(11):3092–3097.
   PubMed Web of Science ®Google Scholar
• Miller D. Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. Clin Ophthalmol. 2008;2(1):77–91.
   PubMedGoogle Scholar
• Biedenbach DJ, Bell JM, Sader HS, et al. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY program report (2003-2004). Int J Antimicrob Agents. 2007;30(2):143–149.
   PubMed Web of Science ®Google Scholar
• Bert F, Noussair L, Lambert-Zechovsky N, et al. Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Eur J Gastroenterol Hepatol. 2005;17(9):929–933.
   PubMed Web of Science ®Google Scholar
• Peyman GA, Paque JT, Meisels HI, et al. Postoperative endophthalmitis: a comparison of methods for treatment and prophlaxis with gentamicin. Ophthalmic Surg. 1975;6(1):45–55.
   PubMedGoogle Scholar
• Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology. 2006;113(4):633–634.
   PubMed Web of Science ®Google Scholar
• Keshav BR, Basu S. Normal conjunctival flora and their antibiotic sensitivity in Omanis undergoing cataract surgery. Oman J Ophthalmol. 2012;5(1):16–18.
   PubMedGoogle Scholar
• Moss JM, Sanislo SR, Ta CN. Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections. Ophthalmology. 2010;117(11):2141–2145.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Toma HS, Midha NK, et al. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology. 2010;117(12):2372–2378.
   PubMed Web of Science ®Google Scholar
• Wen JC, McCannel CA, Mochon AB, et al. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol. 2011;129(12):1551–1554.
   PubMedGoogle Scholar
• Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 2012;32(3):473–476.
   PubMed Web of Science ®Google Scholar
• Liu W, Liu QF, Perkins R, et al. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials. Antimicrob Agents Chemother. 1998;42(6):1417–1423.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Kuruvilla O, Yee DC, et al. Intraocular penetration of systemic antibiotics in eyes with penetrating ocular injury. J Ocul Pharmacol Ther. 2014;30(10):823–830.
   PubMed Web of Science ®Google Scholar
• Ferencz JR, Assia EI, Diamantstein L, et al. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol. 1999;117(8):1023–1027.
   PubMedGoogle Scholar
• Araujo FG, Slifer TL, Remington JS. Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clin Microbiol Infect. 2002;8(1):26–30.
   PubMed Web of Science ®Google Scholar
• Sanders ME, Norcross EW, Moore QC, et al. A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model. Clin Ophthalmol. 2008;2(4):793–800.
   PubMedGoogle Scholar
• Sanders ME, Norcross EW, Moore QC 3rd, et al. Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis. J Ocul Pharmacol Ther. 2010;26(6):571–577.
   PubMed Web of Science ®Google Scholar
• Park SS, Samiy N, Ruoff K, et al. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol. 1995;113(10):1324–1329.
   PubMedGoogle Scholar
• Cheng HM, Hughes MS, Lashkari K, et al. Proton magnetic resonance spectroscopy of vitreal changes in experimental streptococcal endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 1993;231(7):402–404.
   PubMed Web of Science ®Google Scholar